Dr. Hanne Scholz is a senior scientist at the Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway and the director of the human islet isolation facility performing clinical islet transplantation for treatment of type 1 diabetes in Norway. Dr. Scholz leads a major research program within Department of Transplantation, Institute for Surgical Research and University of Oslo which aim to improve and optimize islet isolation, beta cell replacement therapies and improve patient outcomes. The Scholz lab has led to multiple publications involving regenerative medicine projects such as development of new cellular therapies for diabetes using stem cells and 3D bio-printing of biomimetic pancreatic islets. Her research programme is extremely multidisciplinary and comprises clinician, transplant surgeon, technicians, postdoctoral researchers and students in different disciplines. The Scholz group is part of the Hybrid Technology Hub-Organ on a chip, a Centre of Excellence at University of Oslo aiming to develop “organ on a chip” platforms of functional metabolic human tissue. Dr. Scholz is active board member of the Nordic Network for Clinical Islet Transplantation, member of Oslo Diabetes Research Center, and councilor of the International Pancreas and Islet Transplantation Association (IPITA 2017-2021) and European Society for Organ Transplantation (ESOT 2019-2023).